Today: 8 June 2026
RELX share price today: stock edges up as buybacks keep traders watching
27 February 2026
1 min read

RELX share price today: stock edges up as buybacks keep traders watching

London, Feb 27, 2026, 08:14 GMT — Regular session

RELX (REL.L) edged up 0.5% to 2,537.78 pence Friday morning in London. The information and analytics firm, listed on the LSE, surged 6.25% Wednesday, followed by a 4.55% gain Thursday.

RELX has emerged as something of a bellwether for the bruised software-and-data sector, bouncing back after AI turmoil rattled the group earlier this month. The FTSE 100 notched a record close on Thursday, with RELX up 4.6%—part of a wider snapback fueled by hopes that the Bank of England will trim rates again in March. “It is likely that the UK index’s outperformance is here to stay,” said Axel Rudolph, senior financial analyst at IG. Reuters

RELX has been in the market, picking up 500,000 of its own shares on Thursday via UBS, the company disclosed. Purchase prices landed between 2,386 and 2,523 pence, with the shares earmarked for treasury. That takes its tally since Jan. 2 to 19,730,085 shares bought back.

RELX is pressing ahead with an irrevocable, non-discretionary buyback, according to a U.S. filing, planning to spend £450 million between Feb. 12 and March 20. That comes right after wrapping up a £250 million programme on Feb. 6. In these setups, the broker sticks to preset rules, so share repurchases keep going, closed period or not.

RELX, in a fresh filing this week, moved to secure a block listing for 80,000 shares under its employee share purchase plan. The shares are set to be admitted on March 2.

AI is where the real debate is. RELX, earlier this month, flagged its AI-powered products as growth engines for “many years to come.” Finance chief Nick Luff says the company’s data and algorithms give professional users “the right judgments.” The previous selloff? That one rippled through rivals Wolters Kluwer and Thomson Reuters after Anthropic, the AI player, rolled out a plugin for its Claude chatbot. Reuters

The rally, though, could unravel in a hurry if the AI narrative sours again or enthusiasm for software-and-data stocks cools off. Buybacks might keep shares in check, but they can’t prop up sentiment. When risk appetite slips, stocks fueled by buzz tend to feel it right away.

RELX is set to deliver a trading update during its annual general meeting on April 23, marking the next major company event.

Stock Market Today

  • Cotton Futures Bounce Back in Early Monday Trading
    June 8, 2026, 11:32 AM EDT. Cotton futures recovered Monday morning, rising 20 to 56 points after steep declines Friday, including a 240-point drop in July contracts. The US dollar index gained 0.643 points to 100.025, while falling crude oil prices pressured markets. Weekly CFTC data showed speculators cut 1,798 cotton contracts, leaving a net long position at 52,402. USDA export sales reached 11.33 million running bales (RB), slightly down 1% from last year but on pace with projections. Certified cotton stocks at ICE fell to 250,429 bales, with prices mixed: July cotton up 57 points, December up 41, and March futures up 27 points after Friday's losses. Market watchers see these shifts amid export totals matching expectations and ongoing commodity volatility.

Latest articles

Dow Jones gains with chip stocks ahead of inflation data

Dow Jones gains with chip stocks ahead of inflation data

8 June 2026
Chip stocks surged, powering the Nasdaq up 1.72% and the S&P 500 1.09% higher, while the Dow rose 0.48% to 51,110 as investors bought back Friday’s losses after a strong jobs report fueled Fed-rate worries; May CPI inflation data Wednesday and oil prices remain key risks for market direction.
Growth ETFs Draw Attention Again as Investors Eye Big Tech Weighting

Growth ETFs Draw Attention Again as Investors Eye Big Tech Weighting

8 June 2026
Invesco QQQ Trust surged 2.2% and Vanguard growth ETFs gained over 1% as tech stocks rebounded, spotlighting growth ETFs’ outperformance—VUG returned 15.42% annually over five years, beating VOO—amid record $7.43 billion U.S. equity fund inflows driven by AI-led rallies, but concentrated tech bets mean higher volatility if sentiment shifts, especially with inflation and Fed risks looming.
Alphabet’s $80 billion AI stock sale puts Google’s rally to the test

Alphabet AI Search Drives Wall Street Target Hikes, Cloud Margins Still Draw Scrutiny

8 June 2026
Alphabet has ordered over 3 million TPUs from Intel for 2028 as it ramps up AI infrastructure, prompting Piper Sandler to raise its price target to $445 on rapid AI-assisted search growth, while UBS warns faster Google Cloud TPU revenue could pressure margins; Alphabet shares recently traded at $362.21, down $6.32, after boosting its equity offering to $84.75 billion to finance the AI buildout.
$95 Billion Dividend ETF May Not Be As Safe As It Looks

$95 Billion Dividend ETF May Not Be As Safe As It Looks

8 June 2026
SCHD’s top 10 holdings now make up about 43.5% of assets, raising concentration risk just as investors pile in for safety after a tech-led selloff; with $95.17 billion in assets, a 3.24% yield, and a 0.06% expense ratio, SCHD traded up 0.4% to $32.44 Monday, but its performance and risk profile now hinge more than ever on a handful of big stocks.
Wall Street’s Chip Rebound Lifts Nasdaq — Inflation Test Comes Next

Wall Street’s Chip Rebound Lifts Nasdaq — Inflation Test Comes Next

8 June 2026
Intel soared 8.5% to lead a 4.6% surge in chip stocks after reports Alphabet tapped it to make 3 million in-house chips and Nvidia was evaluating its technology, powering a 1.43% Nasdaq jump as investors returned to AI trades ahead of Wednesday’s key inflation data; Citigroup raised its S&P 500 target to 8,100, but Goldman Sachs warned the Fed may keep rates unchanged through 2026.
Intel stock slides as chip rally cools — what’s driving INTC today
Previous Story

Intel stock slides as chip rally cools — what’s driving INTC today

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Next Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

Go toTop